Picton Mahoney Asset Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Picton Mahoney Asset Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-499,998	Closed	-$5.02M	–	876
2022 Q2	$5.02M	Hold	499,998	–	–	0.19%	123
2022 Q1	$5M	Buy	+499,998	New	+$5M	0.18%	137

Other funds holding ARCK

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Picton Mahoney Asset Management's ARCK Position: Q3 2022 in Review

Picton Mahoney Asset Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q3 2022, closing a stake of 499,998 shares — an estimated $5.02M sold.

Picton Mahoney Asset Management first reported a position in ARCK in Q1 2022 and held it in 2 quarters. The position peaked at $5.02M in Q2 2022. 62 funds tracked by Wall St. Rank hold ARCK as of Q3 2022.

Picton Mahoney Asset Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Picton Mahoney Asset Management sold 499,998 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q3 2022, an estimated $5.02M.
Picton Mahoney Asset Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 2 quarters.
Picton Mahoney Asset Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $5.02M in Q2 2022.
62 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q3 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2022, filed 9 Nov 2022.